Original articleDesign and synthesis of new N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents

Add time:09/01/2019    Source:sciencedirect.com

Twenty-four new dipeptide analogs (1–24) of aurantiamide acetate were designed, synthesized, and assayed for effects on superoxide anion generation and elastase release by human neutrophils in response to fMLP/CB. Among them, seven N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides (6, 9, 12, 14, 17, 18 and 20) showed potent inhibitory effects. Compounds 9 and 18 showed the most selective effects against human neutrophil elastase release, with IC50 values of 0.8 ± 0.1 and 1.7 ± 0.6 μM, respectively, and were 130-fold more potent than phenylmethylsulfonyl fluoride (PMSF), the positive control, in this anti-inflammatory assay. These two compounds could be developed as new lead anti-inflammatory agents.

We also recommend Trading Suppliers and Manufacturers of Valine, N-(methoxycarbonyl)- (cas 111398-44-8). Pls Click Website Link as below: cas 111398-44-8 suppliers

Prev:Determination of extracellular and intracellular enrichments of [1-13C]-α-ketoisovalerate using enzymatically converted [1-13C]-valine standardization curves and gas chromatography–mass spectrometry
Next:Original InvestigationNephrotic proteinuria has no net effect on total body protein synthesis: Measurements with 13C valine)